The new article datelined yesterday gives an estimated primary completion date of June 2028. Oh joy. I'll keep whistling along and think pleasant thoughts about partnerships etc, because that will happen before then (here's some cash and some stock and a bigger cash pile when milestones are hit. Now step aside--you can do it, but we are big and can do it faster). On this schedule, some of our trial participants haven't even been diagnosed yet. Oncology advancement is tough.